EPISODE · Apr 25, 2024 · 34 MIN
Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
from Keeping Current CME
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA). Credit available for this activity expires: 4/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
0:00
34:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 34 minutes long.
When was this Keeping Current CME episode published?
This episode was published on April 25, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!